Team:Washington/Project/Safety/Secretion

From 2010.igem.org

Revision as of 19:14, 7 September 2010 by Lsaustin (Talk | contribs)

Our work on Gram-negative Therapeutics was done only on non-pathogenic strains. We used the Type VI Secretion System from Pseudomonas aeruginosa PAO1. All modifications and testing of plasmids and fosmids were in non-pathogenic E. Coli strains, namely EPI300, SW102, and BL21. And Team Tse2's strain...MPI??

Anthrax Work       Meet the Team